Merit Medical Systems, Inc. (MMSI), a healthcare technology company, Tuesday said that its Wrapsody Cell-Impermeable Endoprosthesis (CIE) received approval from Health Canada.
Cell-Impermeable Endoprosthesis is a device typically used in hemodialysis patients to help in treating stenosis or narrowing of blood vessels. The Wrapsody CIE was developed to treat patients on hemodialysis who experience vascular access stenosis.
The approval was supported by positive results from the Wrapsody Arteriovenous Access Efficacy (WAVE) study.
The company said it plans to begin immediate commercialization of the device throughout Canada.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.